The goal of The Leukemia & Lymphoma Society’s Beat AML Master Trial is to change the treatment paradigm for patients with acute myeloid leukemia (AML) by developing more effective, targeted treatments and accelerating their approval. To learn more, go to www.lls.org/BeatAML